Method for treating a neurological disorder comprising administering ASM inhibitors
Abstract:
The present invention relates to a method for treating degenerative neurological disorders in a subject in need thereof, comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising an acid sphingomyelinase (ASM) activity inhibitor or expression inhibitor as an active ingredient.
Information query
Patent Agency Ranking
0/0